Le Lézard
Classified in: Health
Subject: SVY

Wireless Fetal Monitoring System Market is Expected to Expand at a CAGR of 6.8% During the Forecast Period 2018-2026 - Persistence Market Research


NEW YORK, July 17, 2018 /PRNewswire/ --

Wireless Fetal Monitoring System Market Growth Driven by Increasing Awareness Among Pregnant Women

According to the latest market report published by Persistence Market Research, titled 'Global Wireless Fetal Monitoring System: Industry Analysis (2013-2017) and Forecast (2018-2026)', the global wireless fetal monitoring system is expected to expand at a CAGR of 6.8% during the forecast period 2018-2026. The wireless fetal monitoring systems is segmented based on product type, application, end user and region.

     (Logo: https://mma.prnewswire.com/media/661339/Persistence_Market_Research.jpg )

Wireless Fetal Monitoring System Market: Segmentation and Forecast 

On the basis of product type, the market is segmented into Instruments, Accessories and Consumables. Instruments have the highest demand, Owing to the higher response rate of in wireless fetal monitoring systems. Based on application type, the wireless fetal monitoring system market is segmented into Fetal Heart Rate Monitoring, Intrauterine Pressure Monitoring. Based on end user the market was segmented to Hospitals, Obstetrics and Genecology Clinics and Homecare. Hospitals is said to hold major market share and registering CAGR of 6.6%. The wireless fetal monitoring systems is expected to reach a market value of US$ 2099.9 Mn by 2026 end.

Request Sample Report@ https://www.persistencemarketresearch.com/samples/15769

Wireless Fetal Monitoring System Market: Regional Analysis 

On the basis of region, the market has been segmented into North America, Latin America, Europe, Asia-Pacific, and MEA. North America region dominated the wireless fetal monitoring systems which is estimated to measure around 35.3% of the global market in 2018 and is expected to continue to dominate the overall market partly due to technological advancement and entry of players into the market by launching different products.

Wireless Fetal Monitoring System Market: Competition Analysis 

Global wireless fetal monitoring systems is highly fragmented market owing to the presence of various companies such as General Electric Company, Koninklijke Philips N.V., OBMedical Company, Huntleigh Healthcare Limited (ARJO Family), Sunray Medical Apparatus Co., Ltd., Dixion Vertrieb der Medizingeräte GmbH, Shenzhen Unicare Electronic Co., Ltd.,Shenzhen Jumper Medical Equipment Co.,Ltd., Shenzhen Aeon Technology Co., Ltd., Shenzhen Lai Kang Ning Medical Technology Co., Ltd., Mediana Co., Ltd.

Wireless Fetal Monitoring Systems Market Research Report Overview@ https://www.persistencemarketresearch.com/market-research/wireless-fetal-monitoring-systems-market.asp

Companies are focusing on collaboration to develop new technological advanced products for fetal monitoring. The product type segment of wireless fetal monitoring systems will be boosted by its higher response rate and increasing research activities come up with new product type which leading to inorganic growth in industry players.

Download and View Report TOC, Figures and Tables@ https://www.persistencemarketresearch.com/methodology/15769

Wireless Fetal Monitoring System Market: Taxonomy 

By Product Type 

By Application Type 

By End User 

By Region 

Get full Report Now https://www.persistencemarketresearch.com/checkout/15769

More from PMR's Life Sciences & Transformational Health Market Intelligence: 

Hospital Acquired Infections Control Market Global Market Study on Hospital Acquired Infections Control: Disinfection Equipment Product Type to Dominate by Revenue During 2017-2025: https://www.persistencemarketresearch.com/market-research/hospital-acquired-infection-control-market.asp

Hip Resurfacing Implants Market Hip Resurfacing Implants Market Segmentation By Material Type ( Cobalt Chromium Alloy, Tin Coated, Hybrid Alloy ); By End User ( Hospitals, Ambulatory Surgical Center, Orthopedic Clinics ): https://www.persistencemarketresearch.com/market-research/hip-resurfacing-implants-market.asp

Hospital Beds Market Global Market Study on Hospital Beds: Europe to Dominate; Expected to Attain US$ 2,010.2 Mn Market Value by End of 2020: https://www.persistencemarketresearch.com/market-research/hospital-beds-market.asp

Persistence Market Research Overview 

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact
Persistence Market Research
U.S. Sales Office:
305 Broadway, 7th Floor
New York City, NY 10007
+1-646-568-7751
United States
USA - Canada Toll-Free: 800-961-0353
Email: [email protected]

PMR Latest News:  https://www.persistencemarketresearch.com/news



SOURCE Persistence Market Research Pvt. Ltd.


These press releases may also interest you

at 17:31
The increasing need for radioimmunoassay is mainly driven by the rising occurrence of cancer, infectious diseases, and various other health conditions, along with a growing number of epidemics and pandemics and increasing health awareness. Moreover,...

at 17:00
Avicanna Inc. ("Avicanna" or the "Company") a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is pleased to announce that it has closed a non-brokered private...

at 16:46
Darling Ingredients Inc. announced today that it will host a conference call on Thursday, April 25, 2024, at 9 a.m. Eastern Time (8 a.m. Central Time) to discuss first quarter 2024 financial results, which will be released earlier that day, and...

at 16:45
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved Alecensa® (alectinib) for adjuvant treatment following tumor resection for patients with anaplastic...

at 16:45
Geron Corporation , a late-stage clinical biopharmaceutical company, today reported that it has granted non-statutory stock options to purchase an aggregate of 243,000 shares of Geron common stock as inducements to newly hired employees in connection...

at 16:35
DermTech, Inc. (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today announced that the special committee of its board of directors engaged TD Cowen to conduct a process exploring...



News published on and distributed by: